Back to Journals » Clinical Ophthalmology » Volume 4

Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?

Total article views   Abstract views HTML views PDF downloads Totals
8,277 Dovepress* 8,277 0+ 1,906 8,277
Totals 8,277 0 1,906 8,277
*Since 8 April 2010
+Since July 2016

View citations on Google Scholar